Rabi Hanna, Chairman at Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on X:
“Great talk ASH25! Dr. Paulina Velasquez of St. Jude Children’s Research Hospital focused on solutions to two critical barriers for CAR T cells in AML 1 antigen heterogeneity 2- immunosuppressive tumor microenvironment. For antigen; she discussed dual-targeted CAR constructs.”
More updates from ASH25 on OncoDaily.
